Guanfacine Extended-Release
NDC 24979-536, Guanfacine, tablet, extended release, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-536
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201408
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-536 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE3 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-536-00 | 24979053600 | 100000 TABLET, EXTENDED RELEASE in 1 DRUM (24979-536-00) |
| 24979-536-01 | 24979053601 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-01) |
| 24979-536-10 | 24979053610 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (24979-536-10) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/07a701e2-39b7-4bb1-a7c7-d9baed4ab18aNADAC price for package 24979053601
GET /v1/drugs/nadac/24979053601
Use it
Look up 24979-536 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-536 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-536. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.